NCT01965184

Brief Summary

This is a randomized controlled study of cognitive-behavioral therapy (CBT) for disruptive behavior such as irritability, anger and aggression in children and adolescents. CBT will be compared to Supportive Psychotherapy (SPT) and participants of this study will be randomly assigned (like the flip of a coin) to receive CBT or SPT. Participants will be also asked to complete functional magnetic resonance imaging (fMRI) and electrophysiological (EEG) tasks (recordings/images of brain activity) before and after treatment.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 14, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

October 18, 2013

Completed
27 days until next milestone

Study Start

First participant enrolled

November 14, 2013

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 3, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 3, 2018

Completed
Last Updated

November 18, 2023

Status Verified

November 1, 2023

Enrollment Period

4.7 years

First QC Date

October 14, 2013

Last Update Submit

November 15, 2023

Conditions

Keywords

childcognitive behavioral therapyCBTaggressiondisruptive behaviortreatmentfrustrative non-rewardirritability

Outcome Measures

Primary Outcomes (8)

  • Modified Overt Aggression Scale

    Modified Overt Aggression Scale is a 16-item scale that reflects the frequency and severity of incidents of aggressive behavior. Scores can range from 0 (minimum) to 300 (maximum) with higher scores reflecting worse outcome.

    basline (week 0)

  • Modified Overt Aggression Scale

    Modified Overt Aggression Scale is a 16-item scale that reflects the frequency and severity of incidents of aggressive behavior. Scores can range from 0 (minimum) to 300 (maximum) with higher scores reflecting worse outcome.

    midpoint (week 6)

  • Modified Overt Aggression Scale

    Modified Overt Aggression Scale is a 16-item scale that reflects the frequency and severity of incidents of aggressive behavior. Scores can range from 0 (minimum) to 300 (maximum) with higher scores reflecting worse outcome.

    endpoint (week 12)

  • Modified Overt Aggression Scale

    Modified Overt Aggression Scale is a 16-item scale that reflects the frequency and severity of incidents of aggressive behavior. Scores can range from 0 (minimum) to 300 (maximum) with higher scores reflecting worse outcome.

    follow up (3 months)

  • The Clinical Global Impression - Improvement Score

    The Clinical Global Impression - Improvement Score assigned by an independent evaluator (IE) who will be blind to treatment assignment is the categorical primary outcome measure of aggressive behavior. The CGI-I reflects the IE's assessment of overall change from baseline rated on a scale from 1 to 7 where 1 is very much improved, 2 is much improved, 3 is minimally improved, 4 is no change, 5 is minimally worse, 6 is much worth, and 7 is very much worse. Higher scores reflect worse outcome. By convention, ratings of very much improved (1) or much improved (2) define positive response; all other scores are classified as a negative response.

    basline (week 0)

  • The Clinical Global Impression - Improvement Score

    The Clinical Global Impression - Improvement Score assigned by an independent evaluator (IE) who will be blind to treatment assignment is the categorical primary outcome measure of aggressive behavior. The CGI-I reflects the IE's assessment of overall change from baseline rated on a scale from 1 to 7 where 1 is very much improved, 2 is much improved, 3 is minimally improved, 4 is no change, 5 is minimally worse, 6 is much worth, and 7 is very much worse. Higher scores reflect worse outcome. By convention, ratings of very much improved (1) or much improved (2) define positive response; all other scores are classified as a negative response.

    midpoint (week 6)

  • The Clinical Global Impression - Improvement Score

    The Clinical Global Impression - Improvement Score assigned by an independent evaluator (IE) who will be blind to treatment assignment is the categorical primary outcome measure of aggressive behavior. The CGI-I reflects the IE's assessment of overall change from baseline rated on a scale from 1 to 7 where 1 is very much improved, 2 is much improved, 3 is minimally improved, 4 is no change, 5 is minimally worse, 6 is much worth, and 7 is very much worse. Higher scores reflect worse outcome. By convention, ratings of very much improved (1) or much improved (2) define positive response; all other scores are classified as a negative response.

    endpoint (week 12)

  • The Clinical Global Impression - Improvement Score

    The Clinical Global Impression - Improvement Score assigned by an independent evaluator (IE) who will be blind to treatment assignment is the categorical primary outcome measure of aggressive behavior. The CGI-I reflects the IE's assessment of overall change from baseline rated on a scale from 1 to 7 where 1 is very much improved, 2 is much improved, 3 is minimally improved, 4 is no change, 5 is minimally worse, 6 is much worth, and 7 is very much worse. Higher scores reflect worse outcome. By convention, ratings of very much improved (1) or much improved (2) define positive response; all other scores are classified as a negative response.

    follow up (3 months)

Secondary Outcomes (4)

  • The Child Behavior Checklist

    basline (week 0)

  • The Child Behavior Checklist

    midpoint (week 6)

  • The Child Behavior Checklist

    endpoint (week 12)

  • The Child Behavior Checklist

    follow up (3 months)

Other Outcomes (4)

  • functional magnetic resonance imaging (fMRI)

    baseline (week 0)

  • Electroencephalography (EEG)

    baseline (week 0)

  • functional magnetic resonance imaging (fMRI)

    endpoint (week 12)

  • +1 more other outcomes

Study Arms (2)

Cognitive-Behavioral Therapy for Anger and Aggressive Behavior

EXPERIMENTAL

CBT is a behavioral intervention that consists of 12 weekly sessions. During CBT children are taught various skills for coping with frustration and parents are taught various strategies for managing situations that can be anger provoking for their child.

Behavioral: Cognitive-Behavioral Therapy for Anger and Aggression

Supportive Psychotherapy (SPT)

ACTIVE COMPARATOR

SPT consists of 12 sessions that are focused on discussing peer relationships and family functioning with a goal of enhancing subjective well-being

Behavioral: Supportive Psychotherapy (SPT)

Interventions

Cognitive-Behavioral Therapy for Anger and Aggressive Behavior
Supportive Psychotherapy (SPT)

Eligibility Criteria

Age8 Years - 16 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Boys and girls, 8 to 16 years of age.
  • T-Score \> 65 on the parent-rated Aggressive Behavior Scale of the Child Behavior Checklist (CBCL).
  • Unmedicated or on stable medication for aggression, ADHD, anxiety, or depression for at least 6 weeks, with no planned changes for duration of study.
  • Children can speak English sufficiently enough to participate in CBT and study assessments.
  • Children should have 1) no metal medical implants, 2) a body weight of less than 250 lbs. and 3) no claustrophobia. \[These are necessitated by the safety requirements of the fMRI.\]
  • Children should be able to meet fMRI data quality requirements at baseline \[to enable pre- to post-treatment comparison.\]
  • Families can commute to the Yale Child Study Center in New Haven, CT for weekly visits.

You may not qualify if:

  • IQ below 85.
  • Significant medical condition such as heart disease, hypertension, liver or renal failure, pulmonary disease, seizure disorder, brain injury based on medical history which can interfere with participation in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale University

New Haven, Connecticut, 06520, United States

Location

Related Publications (3)

  • Sukhodolsky, D. G. & Scahill, L. (2012). Cognitive-behavioral therapy for anger and aggression in children. New York: Guilford Press.

    BACKGROUND
  • Sukhodolsky DG, Vitulano LA, Carroll DH, McGuire J, Leckman JF, Scahill L. Randomized trial of anger control training for adolescents with Tourette's syndrome and disruptive behavior. J Am Acad Child Adolesc Psychiatry. 2009 Apr;48(4):413-421. doi: 10.1097/CHI.0b013e3181985050.

    PMID: 19242384BACKGROUND
  • Perlman SB, Pelphrey KA. Developing connections for affective regulation: age-related changes in emotional brain connectivity. J Exp Child Psychol. 2011 Mar;108(3):607-20. doi: 10.1016/j.jecp.2010.08.006. Epub 2010 Oct 23.

    PMID: 20971474BACKGROUND

MeSH Terms

Conditions

Problem BehaviorAggressionPatient Compliance

Interventions

Cognitive Behavioral Therapymycophenolic adenine dinucleotide

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorChild BehaviorAberrant Motor Behavior in DementiaSocial BehaviorPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth Behavior

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Denis G. Sukhodolsky, Ph.D.

    Yale University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 14, 2013

First Posted

October 18, 2013

Study Start

November 14, 2013

Primary Completion

August 3, 2018

Study Completion

November 3, 2018

Last Updated

November 18, 2023

Record last verified: 2023-11

Locations